Procter & Gamble’s net sales in the second quarter of fiscal year 2022 were $21 billion, a 6% increase versus the prior year. Organic sales, which exclude the impacts of foreign exchange, acquisitions and divestitures also increased 6%. The increase in organic sales was driven by a 3% increase in shipment volumes and three percentage points of increased pricing to help offset the significant commodity and other input cost increases. Mix was neutral to net sales growth.

Baby, Feminine and Family Care segment organic sales increased 5% versus a year ago. Baby Care organic sales increased high single digits driven by increased pricing, market growth and positive product mix from the growth of premium taped and pant-style diapers. Feminine Care organic sales increased double digits driven by commodity-based price increases, innovation and positive geographic and product mix. Family Care organic sales were in-line with prior year as pricing benefits were offset by unfavorable mix and lower volumes versus pandemic-related consumption increases in the base period.

“We delivered very strong top-line growth and made sequential progress on earnings in the face of significant cost headwinds,” says Jon Moeller, president and chief executive officer. “These results keep us on track to deliver our earnings outlook and to raise estimates for sales growth, cash productivity and cash return to shareowners. Our focus remains on the strategies of superiority, productivity, constructive disruption and continually improving P&G’s organization structure and culture. These strategies have enabled us to build and sustain strong momentum. They remain the right strategies to deliver balanced growth and value creation.”